UK markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
957.00+19.39 (+2.07%)
At close: 04:00PM EDT
957.00 0.00 (0.00%)
After hours: 07:29PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts23232625
Avg. Estimate10.8712.0544.7147.54
Low estimate9.2710.436.4840.97
High estimate12.8614.3151.5355.84
Year ago EPS10.2411.5943.7944.71
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20192625
Avg. Estimate3.39B3.58B13.91B14.97B
Low estimate3.15B3.34B13.04B13.92B
High estimate3.65B3.76B14.75B16.86B
Year ago salesN/A3.36B13.12B13.91B
Sales growth (year/est)N/A6.30%6.00%7.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS9.8410.7210.7310.09
Actual EPS10.2411.5911.869.55
Difference0.40.871.13-0.54
Surprise %4.10%8.10%10.50%-5.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate10.8712.0544.7147.54
7 days ago10.9112.0245.1547.65
30 days ago10.9511.9144.7847.27
60 days ago11.0411.9344.8347.29
90 days ago11.211.9744.8348.04
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2348
Up last 30 days34611
Down last 7 daysN/AN/AN/AN/A
Down last 30 days9895
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.6.20%N/AN/AN/A
Next qtr.4.00%N/AN/AN/A
Current year2.10%N/AN/AN/A
Next year6.30%N/AN/AN/A
Next 5 years (per annum)7.36%N/AN/AN/A
Past 5 years (per annum)17.45%N/AN/AN/A